ResonanceDx Inc. is an early stage medical diagnostic start-up and is commercializing rapid easy to use diagnostic tests based on antibody-antigen reactions that are quantified via wafer fabricated acoustic resonating sensors. John Ashley, the CEO, shares his perspective on the value of SENIC user facility to his company.